Skadden, Arps, Slate, Meagher & Flom LLP served as legal advisor to SMBC Group, while Cravath, Swaine & Moore LLP and Davis Polk & Wardwell LLP...
Jefferies and SMBC Group’s Strategic Alliance
TELA Bio’s $45.125 Million Common Stock Public Offering
Goodwin Procter advised TELA Bio, while Latham & Watkins advised the underwriters on the offering. TELA Bio, Inc. has announced the pricing of its previously announced underwritten...
Vaxcyte’s $500 Million Public Offering
Cooley advises Vaxcyte on the offering, and Latham & Watkins advises the underwriters. Vaxcyte, Inc. (Nasdaq: PCVX) has announced the pricing of an underwritten public offering...
Mirion Technologies’ $85.6 Million Secondary Offering
Goodwin Procter advised Mirion Technologies on the offering, and Davis Polk advised the underwriter. Mirion Technologies announced the $85.6 million offering of 9,786,153 shares of its Class...
Travere Therapeutics’ $200 Million Public Offering of Common Stock and Pre-Funded Warrants
Cooley advises Travere Therapeutics, and Latham & Watkins advises the underwriters. Travere Therapeutics, Inc. (Nasdaq: TVTX) has announced the pricing of an underwritten public offering of...
InterDigital’s $200 Million Modified Dutch Auction Tender Offer
Paul Weiss represented InterDigital, and Simpson Thacher represented the dealer manager in the operation. InterDigital, Inc. announced a modified “Dutch auction” tender offer for up to...
ImmunityBio’s $50.0 Million Offering
Goodwin Procter advised Jefferies LLC as exclusive placement agent on the deal. ImmunityBio, Inc. (NASDAQ: IBRX), a clinical-stage immunotherapy company, announced that it has executed financing...
Israel Discount Bank’s Senior Bonds Offering
Herzog advised the underwriters on the deal. Israel Discount Bank executed a $800 million senior bonds offering. This is the first international bonds offering for Israel Discount...
CureVac’s $250 Million Common Shares Offering
NautaDutilh and Davis Polk advised CureVac on the offering, while Latham & Watkins advised the underwriters involved. CureVac N.V. announced the pricing of 27,027,028 common shares...
Structure Therapeutics’ $185.3 Million IPO
Cooley LLP represented Structure Therapeutics, while Latham & Watkins LLP represented the underwriters in the offering. Structure Therapeutics, a clinical-stage global biopharmaceutical company, announced its $185.3 million...
Xponential Fitness’ $122.5 Million Secondary Offering of Class A Common Stock
Davis Polk is advising Xponential Fitness on the offering, and Latham & Watkins is advising the underwriters involved. Xponential Fitness, Inc. has announced the pricing of...
Cellectis’ $25 Million Increase in Capital
Gide advised the banking syndicate composed of Jefferies LLC and Barclays Capital Inc. in connection with the capital increase of Cellectis. The banks were represented by...